Novocure Announces $75 Million Drawdown under Its Term Loan Agreement through Pharmakon Advisors
Non-dilutive financing enhances financial strength ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it has provided notice to draw the remaining $75 million under its existing term loan agreement with an investment fund managed by Pharmakon Advisors LP and anticipates receiving funds on July 22, 2016. Novocure drew $25 million of the total $100 …